Advancedtmjsleep
- Laser Therapy (LLLT)
- Sleep Apnea Treatment
- Migraine Treatment
- TMJ Treatment
Seattle, WA
Migraine Treatment clinics in Seattle
Seattle has 4 providers offering migraine care, spanning conventional neurology and regenerative or integrative options. The conventional stack includes triptans, CGRP inhibitors like Aimovig, Emgality, Ajovy, and Nurtec ODT, and onabotulinumtoxinA (Botox) for chronic migraine, which is FDA-approved for that indication. On the regenerative and device side, eNeura's sTMS mini is FDA-cleared for acute and preventive treatment of migraine with aura. Occipital and sphenopalatine ganglion nerve blocks are commonly used off-label in Seattle clinics, typical cost 150 to 400 dollars per injection. PRP scalp injections and neurofeedback are offered by some integrative practices, though evidence for PRP in migraine is Insufficient. Washington insurers generally cover CGRP inhibitors and Botox for chronic migraine (15 or more headache days per month) when step therapy is documented. A reputable Seattle migraine clinic will start with a neurology evaluation, headache diary, and imaging when red flags are present before escalating to device or procedural options.
Northwest Restorative Medicine
- PRP Therapy
- Shockwave Therapy
- Arthritis Treatment
- Migraine Treatment
- Peptide Therapy
Drip Lounge IV Bar
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
- Hyperbaric Oxygen Therapy (HBOT)
Regulatory context
A note on Washington's migraine treatment rules.
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
-
Washington Medical Practice Act (RCW 18.71)
Defines the practice of medicine and supervision framework for delegated procedures including TMS technician work. -
Washington Psychologist Licensure (RCW 18.83)
Governs licensed psychologists who deliver biofeedback and neurofeedback within scope. -
Washington Naturopathy Licensure (RCW 18.36A)
Permits naturopathic physicians to use biofeedback and certain neuromodulation devices within their defined scope.
The Washington Medical Commission investigates TMS clinics for supervision lapses and off-label marketing. The Washington attorney general enforces the Consumer Protection Act (RCW 19.86) against deceptive medical device advertising, including neurofeedback cure claims. Washington has a large naturopathic and integrative sector where CES and tDCS are sometimes offered, and these face board attention when marketing implies FDA-cleared medical treatment. Commercial insurers and Washington Apple Health typically require documented treatment-resistant depression before covering TMS for major depressive disorder.